Spero Therapeutics board compensation committee approves inducement grant
Spero Therapeutics says its Compensation Committee approved an inducement grant under Nasdaq Listing Rule 5635(c)(4).
CAMBRIDGE, Mass., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.
NASDAQ:SPRO, a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that the Compensation Committee of Spero’s Board of Directors approved…